Corcept Therapeutics Incorporated (CORT)

Receivables turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	482,375	401,858	365,978	353,874	306,486
Receivables	US$ in thousands	42,823	32,857	29,025	27,498	19,928
Receivables turnover		11.26	12.23	12.61	12.87	15.38

December 31, 2023 calculation

Receivables turnover = Revenue ÷ Receivables
= $482,375K ÷ $42,823K
= 11.26

The receivables turnover ratio for Corcept Therapeutics Inc has exhibited a declining trend over the past five years. The ratio decreased from 15.38 in 2019 to 11.73 in 2023. This indicates that the company takes longer now to collect its accounts receivable compared to previous years. While a lower receivables turnover ratio may suggest inefficiencies in collecting outstanding balances, it is important to consider the industry standards and company-specific factors before drawing definitive conclusions about its financial health.